Adult and infant abamectin exposures following Avert 310 and pressurized gel crack and crevice treatment.
Krieger
R I
RI
Department of Entomology, University of California, Riverside 92521, USA.
Rosenheck
L A
LA
Schuester
L L
LL
D000328:Adult; D016902:Air Pollution, Indoor / Q000009:adverse effects* / Q000032:analysis; D000818:Animals; D002140:California; D002851:Chromatography, High Pressure Liquid; D003058:Cockroaches; D004305:Dose-Response Relationship, Drug; D004391:Dust; D004781:Environmental Exposure; D018690:Excitatory Amino Acid Agonists / Q000009:adverse effects* / Q000032:analysis; D005374:Filtration; D006801:Humans; D007231:Infant, Newborn; D007306:Insecticides / Q000009:adverse effects* / Q000032:analysis; D007559:Ivermectin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000032:analysis; D010571:Pest Control; D010573:Pesticide Residues / Q000009:adverse effects* / Q000032:analysis; D011138:Polytetrafluoroethylene / Q000737:chemistry; D011897:Random Allocation; D018570:Risk Assessment; D012869:Skin Absorption / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects
D004391:Dust; D018690:Excitatory Amino Acid Agonists; D007306:Insecticides; D010573:Pesticide Residues; C048324:abamectin; D007559:Ivermectin; C019264:avermectin; D011138:Polytetrafluoroethylene